Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results

Bulletin Express

2025/11/05

Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.

According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1130222871"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130222871\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130222871?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130222871","market":"hk","top_or_hot":-1,"title":"Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results","media":"Bulletin Express","content":"<p>Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.</p>\n<p>According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 06:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.</p>\n<p>According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02633","symbol_name":"雅各臣科研制药","start_time":0,"source_url":"","article_id":"1130222871","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130222871","pubTimestamp":1762294916,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02633":"雅各臣科研制药"},"translate_title":"雅各臣药业(2633)计划于2025年11月18日召开董事会审阅中期业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02633":1},"content_text":"Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.\nAccording to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}